These studies showed that low expression of writers (METTL3, METTL14, WTAP, and ZC3H13, but not KIAA1429) and high expression of erasers (FTO and ALKBH5) contributed to tumorigenesis in BC, suggesting a lower m6A modification in BC patients. Here, METTL14 is linked to breast cancer.